A significant gap remains in fully understanding the precise mechanisms by which Bok influences tumor proliferation and how its expression correlates with clinical outcomes across a broader range of cancer types, moving beyond mouse models to human cohorts. The gene discussed is BOK; the disease is neoplasm.